https://www.law360.com/health/articles/1208/federal-circuit-upholds-lower-court-s-ruling-in-patent-suit-over-laser-eye-surgery-technology?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T02:34:38Z monthly 0.5 https://www.law360.com/health/articles/1199/tyco-ordered-to-pay-135m-in-patent-suit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T19:09:42Z monthly 0.5 https://www.law360.com/health/articles/1188/benitec-sues-biotech-rivals-over-rnai-gene-silencing-technology?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T03:11:51Z monthly 0.5 https://www.law360.com/health/articles/1185/judge-rules-for-cytomedix-in-patent-suit-over-platelet-releasates?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T18:43:58Z monthly 0.5 https://www.law360.com/health/articles/1190/tkt-regains-european-rights-to-dynepo-?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T14:09:55Z monthly 0.5 https://www.law360.com/health/articles/1182/court-rules-mylan-infringes-j-j-duragesic-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T03:35:09Z monthly 0.5 https://www.law360.com/health/articles/1178/canada-committee-reviews-draft-of-landmark-generics-bill?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T11:29:06Z monthly 0.5 https://www.law360.com/health/articles/1170/mylan-sues-procter-gamble-and-watson-over-authorized-generic-?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T13:46:30Z monthly 0.5 https://www.law360.com/health/articles/1162/shire-buys-fosrenol-patent-rights-for-up-to-31-m?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T10:42:08Z monthly 0.5 https://www.law360.com/health/articles/1163/andrx-relinquishes-180-day-exclusivity-for-wellbutrin-generic-ceding-ground-to-eon?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T08:23:09Z monthly 0.5 https://www.law360.com/health/articles/1157/dr-reddy-s-files-fda-anda-for-ucb-epilepsy-drug?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T18:06:01Z monthly 0.5 https://www.law360.com/health/articles/1152/glaxo-loses-patent-for-seretide-advair-in-u-k-?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T20:10:03Z monthly 0.5 https://www.law360.com/health/articles/1125/judge-rules-for-abbott-in-depakote-patent-suit-vs-apotex-unit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T05:45:24Z monthly 0.5 https://www.law360.com/health/articles/1123/waters-pays-18m-to-settle-patent-infringement-suit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T19:57:35Z monthly 0.5 https://www.law360.com/health/articles/1120/aventis-faces-threat-of-generic-competition-for-lovenox-?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T12:52:06Z monthly 0.5 https://www.law360.com/health/articles/1110/pfizer-halts-ranbaxy-s-diflucan-generic-with-court-ruling?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T16:27:07Z monthly 0.5 https://www.law360.com/health/articles/1113/e-u-pharmaceutical-reform-package-comes-into-effect?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T03:30:26Z monthly 0.5 https://www.law360.com/health/articles/1102/glaxo-eyes-court-ruling-on-seritide-patent?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T10:24:48Z monthly 0.5 https://www.law360.com/health/articles/1095/aventis-files-additional-suits-over-allegra-patents?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T16:27:06Z monthly 0.5 https://www.law360.com/health/articles/1101/pfizer-to-sue-drug-maker-seeking-fda-ok-to-market-generic-detrol-?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T00:32:59Z monthly 0.5 https://www.law360.com/health/articles/1099/arthrocare-wins-permanent-injunction-against-smith-nephew-in-patent-infringement-lawsuit-?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T09:44:04Z monthly 0.5 https://www.law360.com/health/articles/1089/epo-board-of-appeal-oks-agennix-patent-claims?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T11:12:55Z monthly 0.5 https://www.law360.com/health/articles/1090/gsk-sues-bentley-in-spain-over-paxil-generic?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T13:34:38Z monthly 0.5 https://www.law360.com/health/articles/1083/fda-oks-generic-version-of-abbott-s-tricor-by-impax-teva?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T01:48:34Z monthly 0.5 https://www.law360.com/health/articles/1074/-impax-receives-final-fda-approval-for-generic-version-of-claritin-d-24-hour?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-10T23:08:12Z monthly 0.5 https://www.law360.com/health/articles/1072/diomed-expands-litigation-vs-vascular-solutions-with-patent-suit?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T18:39:49Z monthly 0.5 https://www.law360.com/health/articles/1058/australian-commission-proposes-amendments-to-patent-law-for-genetic-research?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T10:46:07Z monthly 0.5 https://www.law360.com/health/articles/1059/roche-diagnostics-sues-rivals-over-blood-glucose-monitors?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-12T06:10:58Z monthly 0.5 https://www.law360.com/health/articles/1055/fda-to-disclose-dates-of-complete-generic-applications?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T18:47:26Z monthly 0.5 https://www.law360.com/health/articles/1056/trade-group-blasts-authorized-generic-deals?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T10:03:33Z monthly 0.5 https://www.law360.com/health/articles/1057/judge-sets-deadline-for-post-trial-briefs-in-zyprexa-case?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T06:10:00Z monthly 0.5 https://www.law360.com/health/articles/1046/biogen-idec-pays-20m-to-settle-patent-suit-with-corixa-gsk?utm_source=rss&utm_medium=rss&utm_campaign=section_archive 2026-06-11T05:12:36Z monthly 0.5